Insulin Resistance, Brain Atrophy, and Cognitive Performance in Late Middle–Aged Adults
- Auriel A. Willette, PHD1,2,3,
- Guofan Xu, MD, PHD1,3,4,
- Sterling C. Johnson, PHD1,2,3,
- Alex C. Birdsill, BS1,3,
- Erin M. Jonaitis, PHD3,5,
- Mark A. Sager, MD3,5,
- Bruce P. Hermann, PHD3,5,
- Asenath La Rue, PHD3,5,
- Sanjay Asthana, MD1,3,5 and
- Barbara B. Bendlin, PHD1,3⇓
- 1Geriatric Research Education and Clinical Center, William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin
- 2Waisman Laboratory for Brain Imaging and Behavior, University of Wisconsin-Madison, Madison, Wisconsin
- 3Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
- 4Department of Nuclear Medicine, University of Wisconsin-Madison, Madison, Wisconsin
- 5Wisconsin Alzheimer’s Institute, Wisconsin School of Medicine and Public Health, Madison, Wisconsin
- Corresponding author: Barbara B. Bendlin, .
OBJECTIVE Insulin resistance dysregulates glucose uptake and other functions in brain areas affected by Alzheimer disease. Insulin resistance may play a role in Alzheimer disease etiopathogenesis. This longitudinal study examined whether insulin resistance among late middle–aged, cognitively healthy individuals was associated with 1) less gray matter in Alzheimer disease–sensitive brain regions and 2) worse cognitive performance.
RESEARCH DESIGN AND METHODS Homeostasis model assessment of insulin resistance, gray matter volume, and the Rey Auditory Verbal Learning Test (RAVLT) were acquired in 372 participants at baseline and a consecutive subset of 121 individuals ~4 years later. Voxel-based morphometry and tensor-based morphometry were used, respectively, to test the association of insulin resistance with baseline brain volume and progressive gray matter atrophy.
RESULTS Higher insulin resistance predicted less gray matter at baseline and 4 years later in medial temporal lobe, prefrontal cortices, precuneus, and other parietal gyri. A region-of-interest analysis, independent of the voxel-wise analyses, confirmed that higher insulin resistance was related to medial temporal lobe atrophy. Atrophy itself corresponded to cognitive deficits in the RAVLT. Temporal lobe atrophy that was predicted by higher insulin resistance significantly mediated worse RAVLT encoding performance.
CONCLUSIONS These results suggest that insulin resistance in an asymptomatic, late middle–aged cohort is associated with progressive atrophy in regions affected by early Alzheimer disease. Insulin resistance may also affect the ability to encode episodic information by negatively influencing gray matter volume in medial temporal lobe.
This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10.2337/dc12-0922/-/DC1.
A slide set summarizing this article is available online.
- Received May 12, 2012.
- Accepted July 31, 2012.
- © 2013 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.